📗 Cite This Artifact
rest-protein
REST Protein — RE1-Silencing Transcription Factor
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">rest-protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>REST (RE1-Silencing Transcription Factor) / NRSF</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[REST](/genes/rest)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2W1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~121 kDa (1,098 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus (cytoplasm in disease states)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Zinc finger transcription factor family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>4q12</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Neuron-specific, high in hippocampus and cortex</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">RESTfull (1,098 aa)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">REST4 (724 aa)</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">REST splice variants</td>
<td>Tissue-specific</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">REST overexpression</td>
<td>Research</td>
</tr>
<tr>
<td class="label">HDAC inhibitors</td>
<td>Clinical</td>
</tr>
<tr>
<td class="label">Small molecule activators</
REST Protein — RE1-Silencing Transcription Factor
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">rest-protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>REST (RE1-Silencing Transcription Factor) / NRSF</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[REST](/genes/rest)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2W1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~121 kDa (1,098 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus (cytoplasm in disease states)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Zinc finger transcription factor family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>4q12</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Neuron-specific, high in hippocampus and cortex</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">RESTfull (1,098 aa)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">REST4 (724 aa)</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">REST splice variants</td>
<td>Tissue-specific</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">REST overexpression</td>
<td>Research</td>
</tr>
<tr>
<td class="label">HDAC inhibitors</td>
<td>Clinical</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Domain</td>
</tr>
<tr>
<td class="label">mSin3A-HDAC</td>
<td>RD1</td>
</tr>
<tr>
<td class="label">CoREST</td>
<td>RD2</td>
</tr>
<tr>
<td class="label">G9a</td>
<td>RD2</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>Both domains</td>
</tr>
<tr>
<td class="label">Category</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Synaptic proteins</td>
<td>Synapsin, Synaptophysin</td>
</tr>
<tr>
<td class="label">Ion channels</td>
<td>SCN2A, KCNQ2</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>GRIN1, GABRA1</td>
</tr>
<tr>
<td class="label">Transcription factors</td>
<td>CREB, NPAS4</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">REST activators</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">HDAC inhibitors</td>
<td>Clinical trials</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Peptide mimetics</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer-disease" style="color:#ef9a9a">ALZHEIMER DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">214 edges</a></td>
</tr>
</table>
Introduction
REST (RE1-Silencing Transcription Factor), also historically known as NRSF (Neuron-Restrictive Silencer Factor), is a zinc-finger transcriptional repressor that plays a fundamental role in establishing and maintaining neuronal identity. [@chong1995] First identified for its role in silencing neuronal genes in non-neuronal cells, REST has evolved to be recognized as a master transcriptional regulator that controls hundreds of genes involved in synaptic function, neuronal connectivity, and stress responses. [@bird2002] The protein functions by binding to the RE1 Silencing Element (RSE), a 21-bp regulatory sequence found in the promoters and enhancers of numerous neuronal genes.
REST is uniquely expressed in the nervous system where it serves as a critical guardian of neuronal identity, preventing ectopic expression of neuronal genes in non-neuronal cells and maintaining proper gene expression patterns within neurons themselves. The protein recruits multiple corepressor complexes including CoREST, mSin3A, and various histone deacetylases (HDACs) to orchestrate chromatin remodeling and transcriptional silencing. [@ballas2005]
A key finding that transformed understanding of REST function was the discovery that REST expression declines with normal aging, and this decline is dramatically accelerated in Alzheimer's disease. [@lu2014] This age-related loss of REST function provides a molecular link between aging and neurodegenerative diseases, as REST deficiency leads to dysregulation of neuronal genes, synaptic dysfunction, and enhanced neuronal vulnerability to stress.
The REST gene encodes a 1,098 amino acid protein with a molecular weight of approximately 121 kDa. The protein is expressed primarily in neurons throughout the brain, with highest levels in the hippocampus, cortex, and cerebellum.
Overview
Structure
Domain Architecture
REST possesses a complex multi-domain architecture that enables its diverse functions:
Structural Features
- Bimodal DNA/RNA binding: REST can bind both DNA (via zinc fingers) and RNA (via RBD)
- Multiple protein interaction domains: Enables recruitment of diverse corepressor complexes
- Nuclear localization signal (NLS): Located in the N-terminal region
- Nuclear export signal (NES): Allows cytoplasmic shuttling under certain conditions
- Phosphorylation sites: Multiple serine/threonine residues for regulatory modifications
Isoforms
The REST4 isoform acts as a dominant-negative inhibitor, lacking the RD2 domain and failing to recruit CoREST, leading to derepression of REST target genes.
Normal Biological Function
Transcriptional Repression
REST is a master transcriptional repressor with essential functions:
Gene Targeting
REST binds to RE1 elements in the regulatory regions of hundreds of neuronal genes: [@koz2011]
Mechanism of Repression
REST recruits multiple corepressor complexes:
- HDAC1 and HDAC2 deacetylate histones
- Creates repressive chromatin environment
- HDAC1/2 for histone deacetylation
- G9a for histone H3K9 methylation
- REST corepressors for additional repression
- Chromatin remodeling
Neuronal Development
During development, REST plays crucial roles:
- Neuronal specification: Establishes neuronal gene expression programs
- Differentiation: Promotes exit from cell cycle, neuronal maturation
- Migration: Regulates genes involved in neuronal migration
- Axon guidance: Controls expression of guidance molecules
Synaptic Plasticity
REST regulates synaptic function throughout life: [@zhang2017]
- Synaptic vesicle proteins: Controls expression of proteins required for neurotransmitter release
- Receptor expression: Regulates NMDA and AMPA receptor subunit composition
- Calcium signaling: Modulates calcium-dependent signaling pathways
- Long-term potentiation: REST target genes are required for LTP
Stress Response
REST mediates cellular stress responses:
- Oxidative stress: Protects neurons from oxidative damage
- DNA damage: Recruited to DNA damage response genes
- Cellular stress: Regulates stress-responsive gene expression
- Aging: REST decline contributes to age-related neuronal dysfunction
Role in Alzheimer's Disease
REST dysfunction is strongly implicated in Alzheimer's disease pathogenesis: [@hwang2013][@cao2016]
REST Expression Decline
- Normal aging: REST expression naturally declines with age in the brain
- AD acceleration: Dramatic reduction in AD brain, particularly in hippocampus
- Cellular localization: REST mislocalizes from nucleus to cytoplasm in AD neurons
- Mechanism: Both transcriptional downregulation and protein mislocalization
Consequences of REST Deficiency
Evidence from Studies
- Post-mortem brain: REST mRNA and protein significantly reduced in AD hippocampus
- Mouse models: REST knockout mice show enhanced sensitivity to Aβ toxicity
- Cell culture: REST overexpression protects neurons from amyloid toxicity
- Epigenetic changes: Altered histone acetylation at REST target genes
Therapeutic Implications
REST represents a promising therapeutic target for AD:
Role in Huntington's Disease
REST dysfunction significantly contributes to Huntington's disease pathogenesis: [@tapia2019]
REST Dysfunction in HD
- Mutant huntingtin binding: Mutant huntingtin abnormally binds to REST
- Nuclear import: Impairs REST nuclear localization
- Transcriptional dysregulation: Leads to widespread gene expression changes
- Loss of function: Reduced REST transcriptional repression activity
Target Gene Dysregulation
REST target genes abnormally expressed in HD:
- Neuronal genes: Increased expression of typically silenced genes
- Synaptic proteins: Altered expression affects synaptic function
- Ion channels: Dysregulation affects neuronal excitability
- Trophic factors: Reduced BDNF and other neuroprotective factors
Mechanism
Therapeutic Targeting
- REST nuclear import: Compounds to enhance REST nuclear localization
- Mutant huntingtin: Reduce mutant HTT levels to release REST
- Gene therapy: Restore proper REST function
Role in ALS and FTD
REST is implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD): [@yang2018]
TDP-43 Pathology
- Interaction: REST interacts with TDP-43 (TARDBP)
- Competition: TDP-43 loss-of-function affects REST target genes
- RNA binding: Competition for RNA targets
- Stress granules: REST recruited to stress granules in disease
Gene Expression Changes
- Neuronal genes: Dysregulated expression in motor neurons
- Synaptic dysfunction: Altered synaptic protein expression
- RNA metabolism: Affected by TDP-43 pathology
Common Pathways
- Shared molecular features: Both ALS and FTD involve REST dysfunction
- chromatin regulation: Altered epigenetic control
- Stress response: Enhanced sensitivity to cellular stress
Role in Epilepsy
REST contributes to epileptogenesis: [@yang2014]
- Seizure activity: Alters REST expression and localization
- Synaptic remodeling: Affects excitatory/inhibitory balance
- Gene regulation: Dysregulates neuronal genes
- Therapeutic potential: REST modulators may reduce seizure severity
Role in Drug Addiction
REST participates in reward and addiction pathways: [@grayson2010]
- Dopaminergic signaling: Regulates genes involved in dopamine signaling
- Synaptic plasticity: Controls genes required for reward learning
- Transcription factors: Regulates other addiction-related TFs
Interaction Network
Corepressor Complexes
DNA Targets (RE1-Containing Genes)
Signaling Pathways
- HDAC signaling: Corepressor recruitment
- Kinase pathways: Phosphorylation affects activity
- Calcium signaling: Activity-dependent regulation
- Epigenetic machinery: Chromatin remodeling
Therapeutic Targeting
REST-Targeting Strategies
HDAC Inhibitors
HDAC inhibitors can compensate for REST deficiency:
- Valproic acid: Increases histone acetylation at REST targets
- SAHA (Vorinostat): Clinical trials for neurodegenerative diseases
- MS-275: Selective HDAC inhibitor
- Sodium butyrate: Promotes REST target gene expression
Gene Therapy Approaches
- Viral vectors: AAV-mediated REST expression
- REST isoform delivery: REST4 antagonists
- CRISPR activation: Upregulate REST expression
REST4 Dominant-Negative
- Mechanism: REST4 lacks RD2 domain
- Blocking: Prevents REST4 formation
- Therapeutic: Promote full-length REST expression
Key Research Findings
Recent Advances (2020-2025)
See Also
- [REST Gene](/genes/rest)
- [TCF4 Protein](/proteins/tcf4-protein)
- [CREB1 Protein](/proteins/creb1-protein)
- [FOS Protein](/proteins/fos-protein)
- [CoREST Complex](/mechanisms/corest-complex)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Huntington's Disease](/diseases/huntingtons)
- [ALS](/diseases/als)
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
- [Transcription Factor Dysregulation](/mechanisms/transcription-factor-dysregulation)
External Links
- [UniProt Q9Y2W1](https://www.uniprot.org/uniprot/Q9Y2W1)
- [PDB Structures: 2C3H, 2C4Z](https://www.rcsb.org/)
- [HGNC: REST](https://www.genenames.org/data/hgnc_data.php?hgnc_id:9969)
- [REST Gene Database](https://www.ncbi.nlm.nih.gov/gene/5985)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-rest-protein |
| kg_node_id | RESTPROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-6e0575fc3d25 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-rest-protein'} |
| _schema_version | 1 |
cites (1)
derives from (8)
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-rest-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[rest-protein](http://scidex.ai/artifact/wiki-proteins-rest-protein)
http://scidex.ai/artifact/wiki-proteins-rest-protein